Ramot:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Ramot - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10843
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ramot is a business engagement center of Tel Aviv University that offers technology transfer services. The center manages new technologies from university laboratories to the domestic and commercial markets. It also offers services which include research and development programs, securing appropriate financial support for research, patenting discoveries, and crafting licensing agreements with industry partners capable of propelling. Ramot also provides identifying improvements with market potential. The center offers its services to life sciences and biotechnology, mechanical engineering, agriculture, electronics and electro-optics, defence and security, environmental and cleantech, ICT and media, and medical devices and diagnostics sectors, among others. Ramot is headquartered in Tel Aviv, Israel.

Ramot – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ramot, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ramot, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ramot, Medical Devices Deals, 2012 to YTD 2018 9
Ramot, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ramot, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ramot at Tel Aviv University Enters into Research Agreement with Merck 11
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 12
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 13
Ramot at Tel Aviv University Enters into Research Agreement with Neurimmune 14
Kadimastem Enters into Research Agreement with Ramot at Tel Aviv University 15
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 16
Licensing Agreements 17
BioLight Life Sciences Enters into Licensing Agreement with Fischer Pharma and Ramot 17
Coronis NeuroSciences Enters into Licensing Agreement with Ramot 18
Therapix Biosciences Enters into Licensing Agreement with Ramot at Tel Aviv University 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
Aerie Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 21
Dexcel Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 22
Ramot – Key Competitors 23
Ramot – Key Employees 24
Ramot – Locations And Subsidiaries 25
Head Office 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Ramot, Pharmaceuticals & Healthcare, Key Facts 2
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ramot, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ramot, Deals By Therapy Area, 2012 to YTD 2018 8
Ramot, Medical Devices Deals, 2012 to YTD 2018 9
Ramot, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Ramot at Tel Aviv University Enters into Research Agreement with Merck 11
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 12
Kalytera Therapeutics Enters into Research Agreement with Ramot at Tel Aviv University 13
Ramot at Tel Aviv University Enters into Research Agreement with Neurimmune 14
Kadimastem Enters into Research Agreement with Ramot at Tel Aviv University 15
Rosetta Genomics Enters Into Agreement With Ramot To Develop Nano-Carrier Delivery System To Treat Cancer 16
BioLight Life Sciences Enters into Licensing Agreement with Fischer Pharma and Ramot 17
Coronis NeuroSciences Enters into Licensing Agreement with Ramot 18
Therapix Biosciences Enters into Licensing Agreement with Ramot at Tel Aviv University 19
Stem Cell Medicine Enters into Licensing Agreement with Ramot at Tel Aviv University and Yeda Research and Development 20
Aerie Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 21
Dexcel Pharma Enters into Licensing Agreement with Ramot at Tel Aviv University 22
Ramot, Key Competitors 23
Ramot, Key Employees 24

List of Figures
Ramot, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Ramot, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Ramot, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Ramot, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Ramot, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Ramot, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Ramot:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Andromeda Metals Ltd (ADN):企業の財務・戦略的SWOT分析
    Summary Andromeda Metals Ltd (Andromeda), formerly Adelaide Resources Ltd, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration and development of gold, halloysite-kaolin, lithium, and copper deposits in Australia. Its projects include Moonta …
  • Advanced Proteome Therapeutics Corp (APC):企業の財務・戦略的SWOT分析
    Advanced Proteome Therapeutics Corp (APC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Sagemcom SAS:企業の戦略的SWOT分析
    Sagemcom SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Tp Icap Plc:企業の戦略・SWOT・財務分析
    Tp Icap Plc - Strategy, SWOT and Corporate Finance Report Summary Tp Icap Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Alon USA Energy Inc (ALJ)-石油・ガス分野:企業M&A・提携分析
    Summary Alon USA Energy Inc (Alon USA), a subsdiary of Delek US Holdings, Inc., is a refiner and marketer of petroleum products. The products offered by the company include various grades of gasoline, diesel fuel, jet fuel, petrochemicals, petrochemical feedstocks, asphalt, and other petroleum-based …
  • Waters Corporation (WAT)-医療機器分野:企業M&A・提携分析
    Summary Waters Corporation (Waters) is an analytical instrument manufacturing company. It carries out the design, production, commercialization and servicing of analytical technologies such as high performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC), chromatograp …
  • Range Resources Corporation:企業の戦略・SWOT・財務分析
    Range Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Range Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Solvang ASA (SOLV):企業の財務・戦略的SWOT分析
    Summary Solvang ASA (Solvang) is an oil and gas company that offers LPG and petrochemical gases transportation services. The company operates through its business areas such as semi-refrigerated or ethylene carriers, LGC, and panamax and VLGC. Its semi-refrigerated or ethylene carriers business area …
  • AnaMar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, is a drug discovery company that discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes on the receptors …
  • Tox Free Solutions Ltd (TOX):企業の財務・戦略的SWOT分析
    Tox Free Solutions Ltd (TOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • JEOL Ltd (6951):企業の財務・戦略的SWOT分析
    JEOL Ltd (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Telecom Italia S.p.A.:企業の戦略・SWOT・財務情報
    Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Italia S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Danaher Corp (DHR):企業の財務・戦略的SWOT分析
    Danaher Corp (DHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Midsona AB (MSON B):企業の財務・戦略的SWOT分析
    Summary Midsona AB (Midsona), is a healthcare products manufacturing company that provides personal care products, health foods, and hygiene products. The company’s products include superfood, sports nutrition, dietary supplements, nutritional supplements, organic food, herbal teas, skin-care and be …
  • Globavir Biosciences Inc-医療機器分野:企業M&A・提携分析
    Summary Globavir Biosciences Inc (Globavir) is a specialty biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. Through Globavir’s Drug Discovery Platform (GDDP), it generates a wide range of small molecule c …
  • Spinal Kinetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Spinal Kinetics Inc (SKG) is a medical device company that develops motion preservation systems for treating degenerative diseases of the spine. The company provides products such as M6-C artificial cervical disc and M6-L artificial lumbar disc. The M6 artificial cervical disc offers an opti …
  • Linde AG (LIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. It offers a wide range of compressed, liquefied gases and chemicals. It also offers engineeri …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析
    Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Siemens AG (SIE):医療機器:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆